New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302

Credits: 0.25 AMA PRA Category 1 Credit™
 

 

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302

 

Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.

 

Episode resource links:

• AACE Guideline:  Endocrine Pract: May 2022, 28(5): 528-562
• Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596

 

Guest: Robert A. Baldor, MD

 

Music Credit: Richard Onorato